These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 7694266

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of retinoic acid on the proliferation and secretory activity of androgen-responsive prostatic carcinoma cells.
    Fong CJ, Sutkowski DM, Braun EJ, Bauer KD, Sherwood ER, Lee C, Kozlowski JM.
    J Urol; 1993 May; 149(5):1190-4. PubMed ID: 7683344
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inverse relationships between cell proliferation and basal or androgen-stimulated apolipoprotein D secretion in LNCaP human prostate cancer cells.
    Sugimoto K, Simard J, Haagensen DE, Labrie F.
    J Steroid Biochem Mol Biol; 1994 Nov; 51(3-4):167-74. PubMed ID: 7526888
    [Abstract] [Full Text] [Related]

  • 11. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation.
    Kokontis J, Takakura K, Hay N, Liao S.
    Cancer Res; 1994 Mar 15; 54(6):1566-73. PubMed ID: 7511045
    [Abstract] [Full Text] [Related]

  • 12. Triiodothyronine modulates growth, secretory function and androgen receptor concentration in the prostatic carcinoma cell line LNCaP.
    Esquenet M, Swinnen JV, Heyns W, Verhoeven G.
    Mol Cell Endocrinol; 1995 Mar 15; 109(1):105-11. PubMed ID: 7540569
    [Abstract] [Full Text] [Related]

  • 13. Regulation of proliferation and production of prostate-specific antigen in androgen-sensitive prostatic cancer cells, LNCaP, by dihydrotestosterone.
    Lee C, Sutkowski DM, Sensibar JA, Zelner D, Kim I, Amsel I, Shaw N, Prins GS, Kozlowski JM.
    Endocrinology; 1995 Feb 15; 136(2):796-803. PubMed ID: 7530653
    [Abstract] [Full Text] [Related]

  • 14. 1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
    Zhao XY, Ly LH, Peehl DM, Feldman D.
    Endocrinology; 1997 Aug 15; 138(8):3290-8. PubMed ID: 9231780
    [Abstract] [Full Text] [Related]

  • 15. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR, Sokoll LJ, Dalrymple S, Rosen DM, Gady AM, Bruzek D, Ricklis RM, Isaacs JT.
    Prostate; 2003 Mar 01; 54(4):249-57. PubMed ID: 12539223
    [Abstract] [Full Text] [Related]

  • 16. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines.
    Lin MF, Meng TC, Rao PS, Chang C, Schonthal AH, Lin FF.
    J Biol Chem; 1998 Mar 06; 273(10):5939-47. PubMed ID: 9488733
    [Abstract] [Full Text] [Related]

  • 17. Prostate cancer cells (LNCaP) generated after long-term interleukin 6 (IL-6) treatment express IL-6 and acquire an IL-6 partially resistant phenotype.
    Hobisch A, Ramoner R, Fuchs D, Godoy-Tundidor S, Bartsch G, Klocker H, Culig Z.
    Clin Cancer Res; 2001 Sep 06; 7(9):2941-8. PubMed ID: 11555613
    [Abstract] [Full Text] [Related]

  • 18. The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.
    van Steenbrugge GJ, Groen M, van Dongen JW, Bolt J, van der Korput H, Trapman J, Hasenson M, Horoszewicz J.
    Urol Res; 1989 Sep 06; 17(2):71-7. PubMed ID: 2660395
    [Abstract] [Full Text] [Related]

  • 19. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
    Lee MS, Igawa T, Yuan TC, Zhang XQ, Lin FF, Lin MF.
    Oncogene; 2003 Feb 06; 22(5):781-96. PubMed ID: 12569372
    [Abstract] [Full Text] [Related]

  • 20. Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system.
    Culig Z, Hoffmann J, Erdel M, Eder IE, Hobisch A, Hittmair A, Bartsch G, Utermann G, Schneider MR, Parczyk K, Klocker H.
    Br J Cancer; 1999 Sep 06; 81(2):242-51. PubMed ID: 10496349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.